Archives 2010

• June 16, 2010
  Minapharm Acquires Majority Stake in ProBioGen AG; Dr. Wieland Wolf Appointed New CEO
  More 
   
• June 14, 2010
  to-BBB receives positive opinion for Orphan Drug Designation
  More 
   
• May 17, 2010
  Bayer HealthCare Enhances U.S. Research Strategy with New Innovation Center
  More 
   
• April 29, 2010
  BioMarin Reports Positive Results for Phase I/II Trial for BMN 110 for MPS IVA
  More 
   
• January 07, 2010
  SK3 Group Announces Healthcare of Today's Acquisition of MacuCLEAR
  More 

 

biopharma insight VOL1 Issue 3 Q4 -
The Competitive Intelligence Issue:
Competitive Intelligence: Key Component of Corporate Decision Making
Biotech Alliances IntelligenceThe Recap Portfolio
Life Science Consulting:An Intelligence Source for Biofinance
Competitive Analysis: A Juxtaposition
Competitive Intelligence & Counter-Intelligence

biopharma insight VOL1 Issue 2 Q2 - The Funding Issue:
Angel Investing: The Largest Private Source of
    Capital for Early Stage Entrepreneurs
Canada's Exchanges: An Alternative for Life Science Financing
Mirror, Mirror, What’s Our Valuation?
Ready, AIM, Finance: Why Targeting Alternate
    Sources of Investment Capital Brings Strategic Value
    as Well as Cash to the Business
The Life Science VC Pitch: Making the First
    Impression the BEST!
Grants: A Non-diluting Source of Start-up Money
London’s Alternative Investment Market (AIM)

biopharma insight VOL1 Issue 1 Q1 - The BIO Issue:
Ever Wondered How to Chair a Session at BIO?
Maximizing Your One-on-one Partnering Experience
    at BIO
The Power of One-on-one Partnering at BIO
Marking Pre-meetings Work for Your Company
How a Business Development Firm Can Help You at
   the BIO Conference
BIO on a Budget